Technical Analysis for JNCE - Jounce Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Historical JNCE trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
Bearish Engulfing | Bearish | 0.00% | |
Earnings Movers | Other | 0.00% | |
20 DMA Resistance | Bearish | -6.63% | |
Pocket Pivot | Bullish Swing Setup | -6.63% | |
Doji - Bearish? | Reversal | -6.63% | |
Earnings Movers | Other | -6.63% | |
New Uptrend | Bullish | -0.27% | |
Oversold Stochastic | Weakness | -0.27% | |
New Downtrend | Bearish | 0.27% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
1.5x Volume Pace | about 19 hours ago | |
Fell Below 10 DMA | about 19 hours ago | |
10 DMA Support | about 19 hours ago | |
20 DMA Resistance | about 19 hours ago | |
Down 5% | about 19 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/25/2021
Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. Jounce Therapeutics, Inc. is based in Cambridge, United States.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Immunology Solid Tumors Immune System Natural Sciences Immunotherapy Monoclonal Antibodies Monoclonal Antibody
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Immunology Solid Tumors Immune System Natural Sciences Immunotherapy Monoclonal Antibodies Monoclonal Antibody
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 14.08 |
52 Week Low | 2.85 |
Average Volume | 486,112 |
200-Day Moving Average | 7.49 |
50-Day Moving Average | 9.70 |
20-Day Moving Average | 11.85 |
10-Day Moving Average | 11.23 |
Average True Range | 0.96 |
ADX | 32.15 |
+DI | 23.91 |
-DI | 17.72 |
Chandelier Exit (Long, 3 ATRs ) | 11.20 |
Chandelier Exit (Short, 3 ATRs ) | 12.66 |
Upper Bollinger Band | 13.44 |
Lower Bollinger Band | 10.26 |
Percent B (%b) | 0.23 |
BandWidth | 26.86 |
MACD Line | 0.26 |
MACD Signal Line | 0.51 |
MACD Histogram | -0.2538 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 12.89 | ||||
Resistance 3 (R3) | 13.06 | 12.61 | 12.57 | ||
Resistance 2 (R2) | 12.61 | 12.12 | 12.52 | 12.46 | |
Resistance 1 (R1) | 11.79 | 11.82 | 11.57 | 11.62 | 12.36 |
Pivot Point | 11.34 | 11.34 | 11.22 | 11.25 | 11.34 |
Support 1 (S1) | 10.52 | 10.85 | 10.30 | 10.35 | 9.60 |
Support 2 (S2) | 10.07 | 10.55 | 9.98 | 9.50 | |
Support 3 (S3) | 9.25 | 10.07 | 9.39 | ||
Support 4 (S4) | 9.08 |